Moreover, due to its role in arterial wall mineralization, PHOSPHO1, can be considered as a therapeutic target for cardiovascular disorders, obesity and diabetes [66]. This evidence concerns the gene PHOSPHO1 and obesity due to melanocortin 4 receptor deficiency.